376 related articles for article (PubMed ID: 9720777)
1. Comparison of rSP-C surfactant with natural and synthetic surfactants after late treatment in a rat model of the acute respiratory distress syndrome.
Häfner D; Germann PG; Hauschke D
Br J Pharmacol; 1998 Jul; 124(6):1083-90. PubMed ID: 9720777
[TBL] [Abstract][Full Text] [Related]
2. A rat model of acute respiratory distress syndrome (ARDS) Part 2, influence of lavage volume, lavage repetition, and therapeutic treatment with rSP-C surfactant.
Häfner D; Germann PG
J Pharmacol Toxicol Methods; 1999; 41(2-3):97-106. PubMed ID: 10598681
[TBL] [Abstract][Full Text] [Related]
3. Dose-response comparisons of five lung surfactant factor (LSF) preparations in an animal model of adult respiratory distress syndrome (ARDS).
Häfner D; Beume R; Kilian U; Krasznai G; Lachmann B
Br J Pharmacol; 1995 Jun; 115(3):451-8. PubMed ID: 7582456
[TBL] [Abstract][Full Text] [Related]
4. Effects of early treatment with rSP-C surfactant on oxygenation and histology in rats with acute lung injury.
Häfner D; Germann PG; Hauschke D; Kilian U
Pulm Pharmacol Ther; 1999; 12(3):193-201. PubMed ID: 10419839
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-inhibition enhances the effects of rSP-C surfactant therapy in a rat lavage model of acute respiratory distress syndrome (ARDS).
Häfner D; Ibrahim M; Wollin L; Germann PG
Exp Toxicol Pathol; 2003 Jul; 55(1):59-68. PubMed ID: 12940630
[TBL] [Abstract][Full Text] [Related]
6. Effects of lung surfactant factor (LSF) treatment on gas exchange and histopathological changes in an animal model of adult respiratory distress syndrome (ARDS): comparison of recombinant LSF with bovine LSF.
Häfner D; Germann PG; Hauschke D
Pulm Pharmacol; 1994 Oct; 7(5):319-32. PubMed ID: 7626919
[TBL] [Abstract][Full Text] [Related]
7. Effects of rSP-C surfactant on oxygenation and histology in a rat-lung-lavage model of acute lung injury.
Häfner D; Germann PG; Hauschke D
Am J Respir Crit Care Med; 1998 Jul; 158(1):270-8. PubMed ID: 9655740
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone enhances the activity of rSP-C surfactant but not of exosurf in a rat model of the acute lung injury.
Häfner D; Germann PG
J Pharmacol Toxicol Methods; 1999 Sep; 42(1):39-48. PubMed ID: 10715602
[TBL] [Abstract][Full Text] [Related]
9. Intratracheally applied rSP-C surfactant exhibits no anaphylactic shock reactions in a guinea pig model of acute lung hypersensitivity.
Germann PG; Kemkowski J; Hauschke D; Steinhilber W; Häfner D
Exp Toxicol Pathol; 1999 Nov; 51(6):495-505. PubMed ID: 10661808
[TBL] [Abstract][Full Text] [Related]
10. Additive effects of phosphodiesterase-4 inhibition on effects of rSP-C surfactant.
Häfner D; Germann PG
Am J Respir Crit Care Med; 2000 May; 161(5):1495-500. PubMed ID: 10806144
[TBL] [Abstract][Full Text] [Related]
11. Effects of C1 inhibitor and r-SP-C surfactant on oxygenation and histology in rats with lavage-induced acute lung injury.
Vangerow B; Häfner D; Rueckoldt H; Marx G; Ott N; Leuwer M; Frerking I; Germann PG
Intensive Care Med; 2001 Sep; 27(9):1526-31. PubMed ID: 11685347
[TBL] [Abstract][Full Text] [Related]
12. Protein- and lipid modification of natural bovine surfactant. Effects in experimental lung failure with special consideration of the response in neonates.
Gortner L; Maroske W; Reiss I; Weller E
Arzneimittelforschung; 2006; 56(1):25-32. PubMed ID: 16478002
[TBL] [Abstract][Full Text] [Related]
13. Different effects of surfactant proteins B and C - implications for development of synthetic surfactants.
Curstedt T; Johansson J
Neonatology; 2010 Jun; 97(4):367-72. PubMed ID: 20551705
[TBL] [Abstract][Full Text] [Related]
14. Exogenous surfactant administration by asymmetric high-frequency jet ventilation in experimental respiratory distress syndrome.
Calkovska A; Sevecova-Mokra D; Javorka K; Petraskova M; Adamicova K
Croat Med J; 2005 Apr; 46(2):209-17. PubMed ID: 15849841
[TBL] [Abstract][Full Text] [Related]
15. Intratracheal surfactant administration restores gas exchange in experimental adult respiratory distress syndrome associated with viral pneumonia.
van Daal GJ; So KL; Gommers D; Eijking EP; Fiévez RB; Sprenger MJ; van Dam DW; Lachmann B
Anesth Analg; 1991 May; 72(5):589-95. PubMed ID: 1850209
[TBL] [Abstract][Full Text] [Related]
16. Animal-derived surfactants versus past and current synthetic surfactants: current status.
Moya F; Maturana A
Clin Perinatol; 2007 Mar; 34(1):145-77, viii. PubMed ID: 17394936
[TBL] [Abstract][Full Text] [Related]
17. A rat model of acute respiratory distress syndrome (ARDS): Part 1. Time dependency of histological and pathological changes.
Germann PG; Häfner D
J Pharmacol Toxicol Methods; 1998 Aug; 40(2):101-7. PubMed ID: 10100499
[TBL] [Abstract][Full Text] [Related]
18. Surfactant and inhaled nitric oxide in rats alleviate acute lung injury induced by intestinal ischemia and reperfusion.
Zheng S; Zhang WY; Zhu LW; Lin K; Sun B
J Pediatr Surg; 2001 Jul; 36(7):980-4. PubMed ID: 11431761
[TBL] [Abstract][Full Text] [Related]
19. Surfactant protein-C in ventilated premature lamb lung.
Ikegami M; Jobe AH
Pediatr Res; 1998 Dec; 44(6):860-4. PubMed ID: 9853918
[TBL] [Abstract][Full Text] [Related]
20. Open lung ventilation preserves the response to delayed surfactant treatment in surfactant-deficient newborn piglets.
van Veenendaal MB; van Kaam AH; Haitsma JJ; Lutter R; Lachmann B
Crit Care Med; 2006 Nov; 34(11):2827-34. PubMed ID: 17006360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
